drugset / Trial / NCT02312739

Nitrous Oxide for Pain Management During In-office Transcervical Sterilization

NCT02312739

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double blind study that aims to measure the difference in maximum pain experienced during in-office transcervical sterilization (Essure®) for women receiving either inhaled nitrous oxide or standard oral analgesia (Vicodin and Lorazepam) with inhaled oxygen. The investigators hypothesize that inhaled nitrous oxide will reduce the pain experienced more than standard oral medications in women undergoing in-office transcervical sterilization.

Timeline

Start
2014-02
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 325 mg Oral
Comparator Hydrocodone Unknown 5 mg Oral
Comparator Lorazepam Small molecule 1 mg Oral
Background Ketorolac Other / unclassified 30 mg Intramuscular

Indications

No indication recorded.